Literature DB >> 24789064

Autoantibodies and disease activity in patients with discoid lupus erythematosus.

Andrew Kim1, Jack O'Brien1, Lin-Chiang Tseng1, Song Zhang2, Benjamin F Chong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24789064      PMCID： PMC4874325          DOI： 10.1001/jamadermatol.2013.8354

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.

Authors:  E Toubi; A Kessel; I Rosner; M Rozenbaum; D Paran; Y Shoenfeld
Journal:  Scand J Immunol       Date:  2006-04       Impact factor: 3.487

2.  Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis.

Authors:  Susan S Copple; Allen D Sawitzke; Andrew M Wilson; Anne E Tebo; Harry R Hill
Journal:  Am J Clin Pathol       Date:  2011-05       Impact factor: 2.493

3.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

4.  Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

Authors:  E J ter Borg; G Horst; E J Hummel; P C Limburg; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1990-05

5.  Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features.

Authors:  D R Synkowski; M Reichlin; T T Provost
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666
  5 in total
  3 in total

Review 1.  Evaluating safety and compatibility of anti-tumor necrosis factor therapy in patients with connective tissue disorders.

Authors:  Jordan T Said; Scott A Elman; Joseph F Merola
Journal:  Ann Transl Med       Date:  2021-03

Review 2.  Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus.

Authors:  Jane L Zhu; Samantha M Black; Benjamin F Chong
Journal:  Ann Transl Med       Date:  2021-03

Review 3.  Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.

Authors:  Alicia J Little; Matthew D Vesely
Journal:  Yale J Biol Med       Date:  2020-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.